Evidence map›Paper›PMID 40567776›Full record

ArticlePeerJ. Computer science2025

Demystifying diagnosis: an efficient deep learning technique with explainable AI to improve breast cancer detection.

Ahmed Alzahrani, Muhammad Ali Raza, Muhammad Zubair Asghar

Abstract read
In one paragraph

Article in PeerJ. Computer science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ahmed AlzahraniDepartment of Computer Science, Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia.ORCID 0000-0002-5010-3249
Muhammad Ali RazaGomal Research Institute of Computing, Faculty of Computing, Gomal University, D.I. Khan, KP, Pakistan.
Muhammad Zubair AsgharGomal Research Institute of Computing, Faculty of Computing, Gomal University, D.I. Khan, KP, Pakistan.ORCID 0000-0003-3320-2074

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As per a WHO survey conducted in 2023, more than 2.3 million breast cancer (BC) cases are reported every year. In nearly 95% of countries, the second leading cause of death for females is BC. Breast and cervical cancers cause 80% of reported deaths in middle-income countries. Early detection of breast cancer can help patients better manage their condition and increase their chances of survival. However, traditional AI models frequently conceal their decision-making processes and are mainly tailored for classification tasks. Our approach combines composite deep learning techniques with explainable artificial intelligence (XAI) to enhance interpretability and predictive accuracy. By utilizing XAI to examine features and provide insights into its classifications, the model clarifies the rationale behind its decisions, resulting in an understanding of concealed patterns linked to breast cancer detection. The XAI strengthens practitioners' and health researchers' confidence and understanding of artificial intelligence (AI)-based models. In this work, we introduce a hybrid deep learning bi-directional long short-term memory-convolutional neural network (BiLSTM-CNN) model to identify breast cancer using patient data effectively. We first balanced the dataset before using the BiLSTM-CNN model. The hybrid deep learning (DL) model presented here performed well in comparison to other studies, with 0.993 accuracy, precision 0.99, recall 0.99, and F1-score 0.99.

Indexed as

BiLSTM+CNNBreast cancer diagnosisCross-fold-validationDisease predictionHybrid deep learningXAI

Identifiers

PMID40567776
PMCPMC12190624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.